29 April 2026
GSK delivers strong Q1 performance and start to 2026 Strong Specialty Medicines performance drives sales and core operating profit growth (Financial Performance – Q1…
AstraZeneca results: Q1 2026 Strong revenue growth and positive readouts from high-value NMEs reinforce confidence in 2030 ambition Revenue and EPS summary Q1 2026…
Coca-Cola Reports First Quarter 2026 Results and Updates Full Year Guidance Global Unit Case Volume Grew 3% Net Revenues Grew 12%; Organic Revenues (Non-GAAP)…
Visa Reports Fiscal Second Quarter 2026 Results San Francisco, CA, April 28, 2026 – Visa (NYSE: V) Ryan McInerney, Chief Executive Officer, Visa, commented…
28 April 2026
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA GSK plc (LSE/NYSE: GSK) today announced that the US Food…
Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older Approval based on KALOS…
27 April 2026
CQS New City High Yield Fund Limited(the Company or Fund) Monthly Factsheet as at 31 March 2026 The Company’s Fact Sheet as at 31 March 2026…
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation GSK plc (LSE/NYSE: GSK) subsidiary, TESARO, Inc., confirms that the Delaware Chancery Court has…